KRISTY ROSTOCIL: Open Payments
NPI 1275205221 · CLEVELAND, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$668 in 15 payments from 7 companies in 2025. Trend: 2023 $628 · 2024 $747 · 2025 $668
Food & beverage: $588Education: $80
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 4 | $334 |
| Astellas Pharma US Inc | 2 | $146 |
| Novartis Pharmaceuticals Corporation | 4 | $77 |
| AstraZeneca Pharmaceuticals LP | 2 | $41 |
| Tempus AI, Inc | 1 | $26 |
| GENZYME CORPORATION | 1 | $26 |
| Merck Sharp & Dohme LLC | 1 | $18 |
Products named: Vyloy, Pemazyre, Zynyz, PLUVICTO, XT CDX, KEYTRUDA, MONJUVI.
Industry payments across OH — which companies pay providers there.
